Close
CDMO Safety Testing 2026
Novotech

Agilent and Tata Institute of Fundamental Research, Hyderabad collaborate to advance scientific frontiers in health and metabolism research

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Transforming the Future of Pharmaceutical Innovation

The pharmaceutical industry stands at the edge of a...

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...
- Advertisement -

In a significant step toward strengthening Indiaโ€™s efforts in nutrition and metabolism research, Agilent Technologies and the Tata Institute of Fundamental Research (TIFR), Hyderabad have announced a strategic collaboration to support ARUMDA (Advanced Research Unit on Metabolism, Development, and Aging). This partnership brings together Agilentโ€™s global expertise in analytical science with TIFRโ€™s research endeavors to address the growing burden of non-communicable diseases (NCDs) and malnutrition in the country.

Agilent and Tata Institute of Fundamental Research Hyderabad MOU Signing

A key outcome of this collaboration is the launch of the Agilentโ€“TIFR Center of Translational Research in Hyderabad. The center will play a pivotal role in supporting the Advanced Research Unit on Metabolism, Development & Aging (ARUMDA)โ€”one of Indiaโ€™s most ambitious government-supported initiatives in human health. ARUMDA is focused on bridging fundamental biology with clinical insights to drive data-driven discovery and inform public health strategies. Agilentโ€™s role centers on enabling this vision through high-performance analytical solutions that support impactful translational research.

This collaboration reflects a shared commitment to advancing science that is rigorous, relevant, and aligned with national health priorities. It is designed to empower researchers with the tools and workflows needed to explore complex biological systems, generate population-specific insights, and translate them into meaningful interventions.

Agilent is contributing to advanced analytical capabilities that support key areas such as molecular profiling, metabolomics, trace element analysis, and cellular bioenergetics. These integrated solutions help researchers navigate the intricacies of human biology and uncover insights that can guide future interventionsโ€”particularly in the context of large-scale, population-based studies. This approach reinforces the collaborationโ€™s focus on enabling science that is both data-driven and impactful.

โ€œOur partnership with TIFR reflects Agilentโ€™s commitment to enabling transformative science through technology, collaboration, and shared purpose,โ€ said Nandakumar Kalathil, Country General Manager, Agilent Technologies India. โ€œWe are proud to support a project of this scale and ambitionโ€”one that aligns with national priorities and has the potential to deliver real-world health impact.โ€

Prof. M. Krishnamurthy, Centre Director, TIFR Hyderabad, added, โ€œThis partnership represents a meaningful step forward in our efforts to translate fundamental research into real-world solutions. The Agilentโ€“TIFR Center of Translational Research will enhance our scientific capabilities and contribute to national efforts in addressing the growing burden of lifestyle-related diseases.โ€

The collaboration also supports the development of a new analytical facility in Hyderabad, established in partnership with the National Analytical Facility for Research in Nutrition and Metabolism, under the ARUMDA umbrella. Aligned with the National Nutrition Mission, the facility is expected to play a critical role in advancing Indiaโ€™s research capabilities in metabolic health and nutrition science.

By combining deep scientific inquiry with advanced analytical technologies, Agilent and TIFR are helping shape a future where research is more connected, more interdisciplinary, and more responsive to the evolving health needs of society. This partnership also reflects Agilentโ€™s long-standing commitment to supporting Indiaโ€™s scientific ecosystemโ€”enabling innovation that spans academia, public health, and industry.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Transforming the Future of Pharmaceutical Innovation

The pharmaceutical industry stands at the edge of a...

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...

Bioprocess Analytics Improving Biologics Manufacturing

The immense complexity of modern biopharmaceutical production is being navigated through the strategic and systematic application of bioprocess analytics improving biologics manufacturing. By leveraging real-time data streams and advanced monitoring tools, manufacturers can gain a granular, molecular-level understanding of cellular behavior and the surrounding environmental conditions within the bioreactor. This proactive, data-driven approach allows for immediate, automated adjustments that optimize therapeutic yield, ensure absolute product consistency, and significantly streamline the arduous path toward commercial-scale production in a highly regulated global environment.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป